Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties

Epithelial ovarian cancer (EOC) is a highly heterogeneous disease with a high death rate mainly due to the metastatic spread. The expression of MDM4, a well-known p53-inhibitor, is positively associated with chemotherapy response and overall survival (OS) in EOC. However, the basis of this associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucà, Rossella, Assenza, Maria Rita, Maiullari, Fabio, Pieroni, Luisa, Maiullari, Silvia, Federici, Giulia, Marini, Federica, Rizzi, Roberto, Urbani, Andrea, Soddu, Silvia, Moretti, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164635/
https://www.ncbi.nlm.nih.gov/pubmed/34052831
http://dx.doi.org/10.1038/s41419-021-03828-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164635/
https://www.ncbi.nlm.nih.gov/pubmed/34052831
http://dx.doi.org/10.1038/s41419-021-03828-z

Ejemplares similares